ASP9853

· Astellas Pharma Global Development, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP9853, covering 2024-11-07 to 2024-11-07. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic Malignancies [Phase 1]

See pricing